Baek Kim

Emory University — United States

Immunology and Microbiology · Life Sciences

53h-index10.2kcitations340works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(132), HIV/AIDS drug development and treatment(79), Virus-based gene therapy research(56), Cytomegalovirus and herpesvirus research(46), RNA modifications and cancer(36)

Publications339 total

CD40 drives tumor growth in non-small cell lung cancer via non-canonical immune-independent mechanisms
Cancer Letters·2025Open Access
Erratum for Dinh et al., “The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir”
mBio·2025Open Access
LAIV Mutations Selectively Alter Influenza Viral RNA Polymerase Function, Favoring Transcription over Genome Synthesis
Viruses·2025Open Access
Addition of hydroxyurea (hydroxycarbamide) enhances the efficacy of fludarabine/cytarabine‐based salvage regimens against acute myeloid leukaemia
British Journal of Haematology·2025· 1 citedOpen Access
Human <i>ribomes</i> reveal DNA-embedded ribonucleotides as a new type of epigenetic mark
2025· 1 citedOpen Access
Blockade of <i>de novo</i> dNTP biosynthesis pathway delays HIV-1 early life cycle kinetics and dynamics
mBio·2025· 1 citedOpen Access
The immunogenicity and protection efficacy evaluation of mRNA vaccine candidate for severe fever with thrombocytopenia syndrome in mice
PLoS neglected tropical diseases·2025· 2 citedOpen Access
Table S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S1 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S1 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S3 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Table S3 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S6 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S5 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S4 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S6 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Figure S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Table S2 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
Table S1 from E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
2025Open Access
page 1 of 17Next →

Frequent Co-authors

Caitlin Shepard(7), Waaqo Daddacha(6), Sarah M. Amie(6), Laura A. Nguyen(6), Joseph A. Hollenbaugh(6), Raymond F. Schinazi(6), Felipe Diaz‐Griffero(5), Tommy E. White(4), Alberto Brandariz-Núñez(4), Vicente Planelles(4), John W. Little(4), Michele B. Daly(4), Si’Ana A. Coggins(4), Thomas Gramberg(3), Nathaniel R. Landau(3), Renate König(3), Stephen Dewhurst(3), Bijan Mahboubi(3), Egbert Flory(2), José Carlos Valle‐Casuso(2)